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Abstract The purpose of our study was (1) to assess retro-
spectively, in healthy subjects and in patients with moderate
and severe functional mitral regurgitation (FMR), the normal
mitral annular dimensions, (2) to determine differences in
mitral annular geometry between healthy subjects and patients
with FMR, and (3) to evaluate potential errors in 2-dimen-
sional (2D) measurements given the 3D nature of the mitral
annulus. 15 patients with no cardiac abnormalities (referred to
as normals), 13 with moderate and 15 with severe FMR as
determined by echocardiography underwent contrast-
enhanced cardiac 64-slice Computed tomography (CT) with
prospective electrocardiography-gating for excluding coro-
nary artery disease. With an advanced visualization, seg-
mentation, and image analysis software, the area,
intercommissural distance (CC), septolateral distance (SLD),
and the anterior and posterior circumference of the MA were
measured in diastole. We found significant (P \ .001) dif-
ferences between normals and patients with severe FMR for
area, SLD and posterior circumference in 3D (P \ .001) and
2D (P \ .001). Similarly, the SLD and the posterior circum-
ference in both 3D (P = .002) and 2D (P = .001) were sig-
nificantly smaller in patients with moderate FMR as compared
to those with severe FMR. In contrast, there were no signifi-
cant differences between groups regarding the CC and the
anterior circumference both in 3D and 2D (all, P [ .05).
Measurements in 3D differed significantly from those with 2D
for all circumference measurements and groups (P \ .01),
with a systematic underestimation of the posterior circum-
ference of 2.1 ± 1.5 mm in normals, 1.8 ± 1.3 mm in
patients with moderate FMR, and 1.9 ± 1.9 mm in patients
with severe FMR for 2D. Our study provides in vivo human
CT data on MA dimensions in normals and patients with
FMR, indicating differences in patients for the area, posterior
circumference and SLD but not for the anterior circumference
and CC. Systematic differences exist between 2D and 3D
measurements for all circumferential measurements.
Keywords Mitral annulus  Circumference  Mitral
regurgitation  Computed tomography
Introduction
Mitral regurgitation (MR) is the second most common
heart valve disease [1]. MR can be the consequence of
primary anatomical changes that affect the leaflets and
subvalvular apparatus (referred to as organic MR), or can
result from left ventricular (LV) remodeling leading to
dislocation of papillary muscles and tethering of leaflets in
the presence of a morphologically normal valve (referred to
as functional MR, FMR) [2]. The most common etiology of
organic MR requiring hospitalization in industrialized
countries is degenerative mitral valve (MV) disease [3],
whereas FMR often occurs in patients with ischemic or
idiopathic dilated cardiomyopathy [4].
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With increased understanding of the heterogenic path-
ophysiology of MR, various techniques were developed for
the repair of mitral valve disease [5], including minimally
invasive approaches [6, 7]. Irrespective of the type of repair
and underlying pathology, annuloplasty is an integral part
of all procedures for restoring the geometry of the dilated
mitral annulus and for enhancing leaflet coaptation [8].
Mitral repair or replacement for FMR in elderly patients
with poor LV function is still associated with significant
mortality and morbidity [9]. The need for less invasive
treatments is driving the field of percutaneous mitral valve
interventions, which includes repair and replacement
techniques [2, 10, 11].
In contrast to open heart surgery where direct
inspection and measurements of the intercommissural
distance and the height of the anterior leaflet is easily
accomplished, the decision for device selection and
planning of the percutaneous approach is based on pre-
procedural imaging. This imaging information usually is
acquired using 2-dimensional (2D) or 3D imaging
modalities such as echocardiography (mitral valve anat-
omy, annular dimensions, spatial relationships) and
fluoroscopy (device positioning and monitoring of
deployment). However, both echocardiography and fluo-
roscopy are subject to limitations that might reduce the
accuracy of measurements.
Computed tomography (CT) represents a well-estab-
lished imaging modality in cardiac imaging, providing
detailed anatomical 3D-information on both coronary
arteries [12] and cardiac valves [13]. Preoperative planning
with cardiac CT has shown to be helpful in planning reo-
perations and minimally invasive cardiac operations [14, 15]
and for accurate depiction of the MV apparatus [16–18].
The purpose of this study was (1) to assess retrospec-
tively, in healthy subjects and in patients with moderate
and severe FMR, the normal mitral annular dimensions, (2)
to determine differences in mitral annular geometry
between healthy subjects and patients with FMR, and (3) to
evaluate potential errors in 2D measurements given the 3D
nature of the mitral annulus.
Materials and methods
Study population
This study was conducted after institutional review board
was obtained. Written informed consent was waived
because of the retrospective nature of the study.
Between October 2008 and October 2010, 13 patients
with moderate FMR (12 male; 69.7 ± 9.6 years; range
53–84 years) and 15 patients with severe FMR (13 male;
65.4 ± 11.1 years; range 47–84 years) as graded by
echocardiography were included in our study. Within the
same time interval, additional 15 patients who were
referred to coronary CT angiography because of a single
episode of atypical chest pain were included as the control
group (10 male; 69.7 ± 9.6 years; range, 44–77 years).
The indication of cardiac CT was the exclusion of coronary
artery disease in patients with atypical chest pain having a
low to intermediate pre-test probability of coronary heart
disease.
Exclusion criteria for CT were nephropathy (serum
creatinine level [150 lmol/L), known hypersensitivity to
iodine-containing contrast medium, non-sinus rhythm and
pregnancy.
All subjects from the control group (subsequently
referred to as normals) were normotensive (blood pressure,
\135/85 mmHg) individuals with sinus rhythm having a
low risk for coronary artery disease (based on Framingham
criteria [19]). All normals underwent transthoracic echo-
cardiography that showed no abnormalities. Normals had
no history of cardiac disease (i.e., myocardial infarction,
cardiac surgery, or intervention), no coronary calcifications
and no non-calcified atherosclerotic plaques based on cal-
cium scoring and CT coronary angiography, respectively.
Catheter angiography was not considered clinically indi-
cated in any of the normals. Exclusion criteria for the
control group were electrocardiography (ECG) abnormal-
ities, history of arterial hypertension, and obesity (body
mass index (BMI), [30 kg/cm2).
CT data acquisition and postprocessing
All CT examinations were performed on a 64-section CT
machine (Somatom Sensation 64, Siemens Medical Solu-
tions, Forchheim, Germany). The scan range covered the
entire heart from the level of tracheal bifurcation to the
diaphragm. No b-blockers were administered prior to CT.
A bolus of 80 mL of nonionic, iodinated contrast material
(Iopromidum, Ultravist 370, 370 mg/mL, Bayer Schering,
Berlin, Germany), followed by 30 mL, saline solution was
continuously injected into a right antecubital vein via a
18-gauge catheter with an injection rate of 5 mL/s. Con-
trast agent application was controlled by bolus tracking. A
region of interest was placed into the aortic root, and image
acquisition started 5 s after the signal density reached the
predefined threshold of 140 Hounsfield units (HU). Data
acquisition was performed in a cranio-caudal direction with
a detector collimation of 32 9 0.6 mm, slice acquisition of
64 9 0.6 mm, gantry rotation time of 330 ms, pitch of 0.2,
tube voltage of 120 kV, and tube current–time product of
330 mAs per rotation. The data acquisition was synchro-
nized to the ECG in a prospective mode. Images were
reconstructed at a slice thickness of 0.75 mm (increment,
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0.5 mm) using a medium-soft tissue convolution kernel
(B26f). The mean dose-length-product of our protocol was
170 ± 34 mGy cm equaling an estimated effective radia-
tion dose of 2.9 ± 0.6 mSv [20].
CT data analysis and anatomical definitions
All data were transferred for post-processing to a personal
computer (Samsung, SyncMaster 2693 HM) equipped with
an advanced visualization, segmentation, and image ana-
lysis software (3mensio Structural Heart 6.0, Pie Medical
Imaging, Maastricht, NL).
The MA circumference was calculated using the
dedicated software by two blinded and independent
readers (with 2 and 5 years of experience in cardiovas-
cular imaging, respectively) as follows: After indepen-
dently placing 16 seed points along the MA (in the long
axis reformation), the circumference of the MA both in
3D and 2D (including the anterior and posterior part),
the mitral annular area, the intercommissural distance,
and the septolateral distance is semiautomatically deter-
mined by the software (Figs. 1 and 2). The time effort
for the measurements of each CT data set using the
dedicated software was on average 5 min. Since the 2D
measurements were determined by the software directly
from the 3D measurements, the time needed for 2D and
3D measurements was similar.
Definitions of the measurements
Area: is the annulus surface calculated when the annulus
is projected to a plane perpendicular through the mathe-
matical center of the mitral annulus.
CC-distance: is the interval between the anterolateral and
posteromedial commissures.
SL-distance: is the length at mid-section from the mitro-
aortic continuity to the lateral wall, perpendicular to the
intercommissural line.
Anterior/Posterior circumference 3D: is the length of the
anterior/posterior mitral annular circumference in the 3D
space.
Anterior/Posterior circumference 2D: is the length of the
anterior/posterior mitral annular circumference in the 3D
space projected to a plane perpendicular to the mathe-
matical center.
Entire circumference 3D: anterior circumference 3D ?
posterior circumference 3D.
Entire circumference 2D: anterior circumference 2D ?
posterior circumference 2D (see Fig. 1).
Statistical analysis
Quantitative variables were expressed as means ± standard
deviations and categorical variables as frequencies or per-
centages. Variables were assessed for normal distribution
using the Kolmogorov–Smirnov test.
To determine the inter-observer agreement between the
two readers, the intraclass correlation coefficient (ICC) was
calculated for each pair of values. According to Landis and
Fig. 1 Measurements in a healthy subject a and a patient with severe
functional mitral regurgitation b. Turquoise line: intersection line for
the short axis; yellow line: intercommissural line; red broken line
(Max): maximum length from septum to lateral wall; red broken line
(mid): length at mid-section from septum to lateral wall (i.e.
septolateral distance); white dot: calculated center of the mitral
annular area; red and white color-coded segments: anterior (white)
and posterior (red) circumference of the MA
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Koch, ICC values of .61–.80 were interpreted as sub-
stantial, and .81–1.00 as excellent agreement [21].
The Fisher’s Exact test was used to compare the gender
distribution between the three groups.
One-way Anova analyses with Bonferroni correction for
multiple comparisons were performed to test for statisti-
cally significant differences in age, area, weight, height,
BMI, CC-distance, SL-distance, anterior/posterior circum-
ference, and entire circumference in 3D and 2D.
Comparisons between the 3D and 2D measurements of
the annular circumference were tested using the paired
t test. In addition, Bland–Altman analysis was performed.
All statistical analyses were conducted using commer-
cially available software (SPSS, release 21.0; SPSS, Chi-
cago, IL, USA). A two-tailed P value\.05 was considered
to indicate statistical significance.
Results
Patients
There were no significant differences between normals and
patients with moderate and severe FMR regarding the age,
gender, weight, height and BMI (all, P [ .05, see Table 1).
Interreader agreement
The interreader agreement was high for all parameters (area:
ICC = .983, P \ .001; CC-distance: ICC = .927, P\ .001;
SL-distance: ICC = .915, P\ .001; anterior circumference
3D: ICC = .909, P \ .001; posterior circumference 3D:
ICC = .982, P \ .001; entire circumference 3D: ICC = .974,
P \ .001; anterior circumference 2D: ICC = .947, P\ .001;
posterior circumference 2D: ICC = .979, P \ .001; entire
circumference 2D: ICC = .977, P \ .001).
Thus, the mean values of the two readers were taken for
further analysis.
Measurements
We found significant (P \ .001) differences between nor-
mals and patients with severe FMR for area, SL-distance
(P \ .001) (Fig. 3a), posterior circumference 3D
(P \ .001) and 2D (P \ .001) (Fig. 3b), as well as for the
entire circumference 3D (P \ .001) and 2D (P \ .001).
There were also significant differences between patients
with moderate and severe FMR for SL-distance, the pos-
terior circumference 3D (P = .002) and 2D (P = .001), as
well as for the entire circumference 3D (P = .001) and 2D
(P = .001) (Table 2).
Fig. 2 Short axis (a and c) and long axis (b and d) reformation of the
mitral valve in a healthy subject in 2D (a and b) and in 3D (c and d);
yellow left ventricle-line: basis for short and long axis reformation
created between the two landmarks (perpendicular to the mitral
annular area, user placed); turquoise line: intersection line for the
short axis reformation; white dot: calculated center of the mitral
annular area; red and white color coded segments: anterior and
posterior circumference of the MA
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In contrast, increases in CC-distance from normals to
patients with FMR were not significant (Fig. 3c), and the
anterior circumferences were similar in both 3D and 2D
among groups (all, P [ .05) (Fig. 3d).
Comparison of 3D versus 2D measurements
The anterior, posterior and the entire circumferences were
significantly different (P \ .001) comparing 3D with 2D
measurements (see Fig. 3b, d). Systematic measurement
errors with underestimation of the posterior circumference
were 2.1 ± 1.5 mm in normals, 1.8 ± 1.3 mm in patients
with moderate FMR, and 1.9 ± 1.9 mm in patients with
severe FMR (Fig. 4).
Discussion
This study confirms [17–19] and extends previous knowl-
edge on MA dimensions in normals and in patients with
various degrees of FMR. Our results indicate the progres-
sive increases in the MA dimensions (area and circumfer-
ence) with increasing degrees of FMR are primarily related
to dilatations of the posterior MA (as indicated by the
SL-distance and posterior circumference) as opposed to the
anterior MA (as indicated by the CC-distance and anterior
circumference). In addition, we demonstrate systematic
errors in determining the mitral annular circumference
using 2D- as compared to 3D-approaches with CT, which
are explained by the 3D nature of the MA.
Currently, several technologies addressing the MA are
under pre-clinical or early clinical evaluation. Under the
definition of indirect annuloplasty, all those devices are
included that are designed to reshape the annulus without a
direct contact, such as coronary sinus implants or cinching
devices. Direct annuloplasty refers to a device designed to
reproduce a surgical annuloplasty procedure. There are
three main direct annuloplasty devices with preliminary
clinical experience. The Bident device (Mitralign inc,
Tewksbury, USA) in which couples of transannular pledgets
are plicated to the posterior annulus in selected locations
[22], resembling the surgical key procedure. The Accucinch
System (Guided Delivery System, Santa Clara, USA) con-
sists of a subannular implant with multiple anchors, con-
nected by a tethering cable which allows echo-guided
posterior annulus remodeling [10]. The Cardioband (Val-
techCardio Inc, OrYehuda, Israel) reproduces a posterior
surgical band, fixated to the native annulus with a series of
helical anchors, which is cinched under echo guidance until
sufficient coaptation is restored [23]. All these technologies
require a preprocedural assessment of MA anatomy for
guiding patient selection and for planning the procedure. In
addition to annuloplasty procedures, preprocedural sizing
could be critical also in the screening process for trans-
catheter mitral valve implantation [11].
Studies using human cadaveric hearts with no evident
cardiac disease revealed entire MA circumferences between
8.0 and 13.4 cm [24–29]. Different methods of specimen
preparation may produce different annular sizes. It is pos-
sible that in formalin preserved hearts the annuli are in
systolic state, whereas if hearts are fresh or examined after
perfusion fixation [29] annuli are in the diastolic state [30].
Using 2D transthoracic echocardiography in healthy
humans, Ormiston et al. [30, 31] measured an average entire
MA circumference of 9.3 cm (8–10.5 cm) in diastole. Using
3D transesophageal echocardiography in healthy subjects,
Khabbaz et al. [32] reported average entire MA circumfer-
ences of 11.4 ± 0.5 cm in systole. Using a 3D approach
with magnetic resonance imaging in normal healthy sub-
jects, Maffessanti et al. [33] found an average diastolic
entire MA circumference of 11.6 cm (11.1–12.5 cm). Our
study revealed an average diastolic entire MA circumfer-
ence of 11.8 ± 0.5 cm for 2D and of 12.3 ± 0.5 cm for 3D
in healthy subjects, being in line with previous reports in
cadavers, 3D echocardiography and magnetic resonance
imaging. The slightly smaller measurements in 2D echo-
cardiography are most probably related to the methods of
image analysis, on assumptions of the geometry of the MA,
or on the inherent limitations of 2D echocardiography that
cannot track distinct anatomic landmarks in time [34].
Table 1 Patient demographics
Patients-overall Normals (n = 15) Moderate FMR (n = 13) Severe FMR (n = 15) P value
Age (mean ± SD) in years 64.2 ± 9.7 69.7 ± 9.6 69.7 ± 9.6 65.4 ± 11.1 0.339
Sex (% male) 81 % (35/43) 66 % (10/15) 92 % (12/13) 87 % (13/15) 0.179
Weight (mean ± SD) in kg 77.1 ± 14.4 80.9 ± 13.2 68.7 ± 13.4 78.4 ± 16.9 0.189
Height (mean ± SD) in m 1.71 ± 6.7 1.73 ± 6.2 1.67 ± 4.1 1.71 ± 9.7 0.214
BMI (mean ± SD) in kg/m2 26.1 ± 4.4 26.9 ± 1.2 24.3 ± 1.6 26.3 ± 1.9 0.459
Ischemic cardiomyopathy 19 0 12 7 NA
Idiopathic dilated cardiomyopathy 9 0 1 8
FMR functional mitral regurgitation, SD standard deviation
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In patients with both moderate and severe FMR, Khabbaz
et al. [32] measured with 3D transesophageal echocardiog-
raphy an average systolic entire MA circumference of
14.1 ± 0.4 cm. Using a 3D approach with magnetic reso-
nance imaging in patients with various degrees of FMR,
Maffessanti et al. [32] reported average diastolic entire MA
circumferences of 12.9 cm (11.0–16.3 cm). Our study
revealed an average diastolic entire MA circumference of
12.6 ± 0.9 cm for 2D and 13.0 ± 0.8 cm for 3D measure-
ments in patients with moderate FMR and 14.2 ± 1.5 cm for
2D and of 14.6 ± 1.6 cm for 3D measurements in patients
with severe FMR.
When comparing 3D with 2D measurements, we found
systematic differences in measurements showing system-
atic underestimations of the posterior circumference
ranging between 1.8 and 2.1 mm in normal and patients
with FMR. This further highlights the 3D nature of the
mitral annulus, which is also a matter of debate regarding
the use of flat or flexible annuloplasty devices for surgery
and intervention.
It has been reported that the anterior MA due to its
fibrous nature is less prone for dilatation [35–37]. The in-
tertrigonal distance may, however, also enlarge, albeit not
as much, in long standing FMR as shown in both experi-
mental [38] and human studies [39]. In our study, the
anterior circumference and the CC-distances were similar
between normal and patients with moderate and severe
FMR. On the other hand, in patients with more severe
degrees of FMR, the posterior circumference increased
significantly that was paralleled by increases of the SL-
Fig. 3 Boxplots showing measurements of the SL-distance (a),
posterior circumference (b), CC-distance (c), and anterior circumfer-
ence (d) between normals and patients with moderate and severe
functional mitral regurgitation (FMR). The horizontal lines in boxes
correspond to the median. The top and bottom of the boxes correspond
to the second and third quartiles. The vertical lines extend to the
median ±1.5 times the interquartile range
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distance. A mismatch between the size of the leaflets and
the SL-distance is one of the main mechanisms inducing
lack of coaptation in FMR. Our data thus suggest that a
procedure for repair of FMR should aim at a shortening of
mainly the posterior MA circumference.
Clinical implications
3D echo has been applied for template-based planning in
minimally invasive mitral valve repair (mostly degenerative
disease) [8, 40, 41]. Pre-operative correlation between the
selected ring size with mitral valve assessment and the actual
implanted annuloplasty ring size was 0.91 demonstrating
that imaging may be useful to guide decision making with
regards to the appropriate selection of a mitral ring implant.
This study has also shown that superimposition of annulo-
plasty ring computer-aided design models on the live 3D
zoom loops of the mitral valve was superior to 2D mea-
surements of the intercommissural distance or the height of
the anterior mitral leaflet, parameters that are routinely used,
in predicting correct annuloplasty ring size [40].
As transcatheter annuloplasty and replacement proce-
dures are currently in the early clinical phase, an exact
measurement of the annular dimensions preoperatively in
will be crucial for appropriate sizing and planning of the
procedure. It is therefore of utmost importance to have a
reliable tool that can accurately predict the size of the
implant.
Recently, it was shown that CT is useful for developing
rapid prototyped personalized mitral valve ring implants
[42]. This may also apply for the development of percuta-
neous mitral valve implants. More than 20 different percu-
taneous mitral valve designs are currently undergoing
preclinical studies. Most of the devices are stent based and
will rely on ‘‘sandwiching’’ the mitral valve leaflets to anchor
stents within the left atrium and the left ventricle [43]. For
these devices it will not only be important to determine the
annular dimensions but also to define the area of possible
landing zones in relation to neighboring structures. CT may
play an important role in planning these procedures.
Our study suggests that CT can be used as a planning
tool for sizing of MA geometry and in especially the MA
circumference before percutaneous catheter-based mitral
interventions. It must be noted that CT screening could
provide additional critical information for proper proce-
dural planning and device selection (e.g. the shape of the
subvalvular apparatus, the distribution of calcium, the
location of the coronary arteries, leaflet anatomy).
Currently there are no recommendations or guidelines,
to our knowledge, stating which measurement technique
(2D or 3D) should be used for clinical routine. This most
probably is related to the fact that most of the minimally
Table 2 Values characterizing the mitral annulus in normals and in patients with moderate and severe functional mitral regurgitation (FMR)
Normals
(n = 15)
Patients with
moderate FMR
(n = 13)
Patients with
severe FMR
(n = 15)
P value
Area (mean ± SD) in cm2 10.2 ± 1.3* 11.8 ± 1.6 15.4 ± 3.4* P \ .001*
CC-distance (mean ± SD) in mm 36.9 ± 3.4 37.4 ± 3.6 40.1 ± 4.6 n.s.
SL-distance (mean ± SD) in mm 30.9 ± 3.4* 35.0 ± 3.0 42.7 ± 6.5* P \ .001*
P \ .001
Anterior circumference 3D (mean ± SD) in mm 45.9 ± 3.4 45.8 ± 4.4 50.2 ± 8.6 n.s.
Anterior circumference 2D (mean ± SD) in mm 43.1 ± 3.3 43.2 ± 4.3 48.4 ± 8.5 n.s.
Posterior circumference 3D (mean ± SD) in mm 77.2 ± 3.6* 84.1 ± 7.7 95.8 ± 11.2* P \ .001*
P = .002
Posterior circumference 2D (mean ± SD) in mm 75.2 ± 3.7* 82.3 ± 8.0 93.8 ± 10.5* P \ .001*
P = .001
Entire circumference 3D (mean ± SD) in mm 123.1 ± 4.9* 130.0 ± 7.6 146.0 ± 16.0* P \ .001*
P = .001
Entire circumference 2D (mean ± SD) in mm 118.1 ± 5.2* 125.5 ± 8.7 142.2 ± 15.3* P \ .001*
P = .001
FMR functional mitral regurgitation, CC-distance shortest intercommissural distance, SL-distance septolateral distance, SD standard deviation
Respective P values are provided in separate column
* indicates significant difference between normals and patients with severe FMR
 indicates significant difference between patients with moderate and severe FMR
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invasive devices mentioned above are not yet widely used
in daily clinical routine. Further experience with trans-
catheter devices in humans will allow for clarification of
the issue whether or not 3D measurements are necessary
for the precise pre-interventional planning.
Study limitations
The following study limitations must be acknowledged.
First, the retrospective nature of our study has inherent
shortcomings. Second, we did not include patients with a
mild FMR because current guidelines do not support early
intervention in this group. Third, we do not have a direct
comparison of CT measurements with those from echo-
cardiography. Finally, due to low radiation dose CT pro-
tocols used in our study, only images in diastole were
available and therefore merely static images of the mitral
valve apparatus were obtained. A retrospective spiral data
acquisition with 4D reconstructions would be needed for
performing measurements in systole and for including the
elements of time and motion.
Conclusions
In conclusion, our study provides in vivo human CT data on
MA dimensions and circumferences measured in both 2D
and 3D in healthy subjects and in patients with FMR. Sig-
nificant differences exist between patient groups regarding
the area, SL-distance and posterior circumference but not
regarding the CC-distance and anterior circumference. In
addition, systematic differences exist between 2D and 3D
measurements for all circumferential measurements.
Fig. 4 Bland and Altman analysis demonstrating the agreement
between 3D and 2D measurements of the posterior circumference in
normals (a), in patients with moderate (b), and in patients with severe
functional mitral regurgitation (c). The mean difference between
methods (solid line) and the limits of agreement (dashed lines) are
shown
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